Loading

Epion Therapeutics

June 03, 2024
Company Presentation
Ophthalmology
Company Presentation Theater 3
*Epion Therapeutics (Epion) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart™ is its transformative cross-linking system targeting keratoconus, a common type of corneal ectasia. EpiSmart is designed to be minimally invasive with reduced discomfort and a significantly reduced recovery time versus current standards of care. Epion's elegant approach will elevate the standard of care for keratoconus by enabling the treatment of both eyes simultaneously to inhibit further progression. With a true epithelium-on approach that does not chemically or mechanically disrupt the epithelium, Epion is striving to deliver safer and more accessible vision-preserving care to millions of patients globally.
Epion Therapeutics
Company Website: https://www.epiontx.com
Lead Product in Development: EpiSmart, a novel drug-device combination for epithelium-on cross-linking treatment of keratoconus

Company HQ City

Burlington

Company HQ State

MA

Company HQ Country

United States

CEO/Top Company Official

Michael D. Webb

Development Phase of Primary Product

Phase III
Speakers
Michael Webb
CEO
Epion Therapeutics, Inc.
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS